Action Needed Against Alternative Funding Vendors
The House Energy and Commerce Health Subcommittee planned to markup 17 bills, but instead, the subcommittee only worked on six; Federal Trade Commission expands its probe into pharmacy benefit managers and group purchasing organizations; Carl Schmid,...
The House Energy and Commerce Health Subcommittee planned to markup 17 bills, but instead, the subcommittee only worked on six; Federal Trade Commission expands its probe into pharmacy benefit managers and group purchasing organizations; Carl Schmid, Executive Director of the HIV and Hepatitis Policy Institute, explains what alternative funding vendors are and how they’re another deterrent to patients getting affordable care; and the House Appropriations Committee releases an FDA funding bill.
House Energy and Commerce Health Subcommittee Meeting
Fierce Healthcare News Article: FTC expands probe into pharmacy benefit managers to GPOs
Patients Rising Webpage: Patients Rising Stories
Carl Schmid
Executive Director, HIV + Hepatitis Policy Institute
Executive Director, HIV + Hepatitis Policy Institute
Listen On
